Clinical and Laboratory Characteristics of Patients with COVID-19 on the Background of Cardiovascular Diseases

The research studied the clinical and laboratory characteristics of COVID-19 patients against background cardiovascular diseases. A high prevalence diseases (CVD) was revealed among patients: arterial hypertension (93.4%), chronic heart failure (60.9%), cardiac arrhythmias (40.1%), coronary disease (21.9%). reliable correlation established between timing hospitalization from onset severity infection, mortality higher in persons hospitalized on 5–7 day (59.8%). Patients with CVD are significantly more likely to develop complications, as well deaths (11.53% vs. 4.30%). Pulmonary embolism (44%), acute respiratory distress syndrome (22%), kidney injury (20.6%) prevailed structure causes death. Gender differences course outcomes were found: rates males. According indicators, system had a severe degree immuno-inflammatory reactions compared group without premorbid background. Upon admission hospital, have lesion pulmonary parenchyma CT 3 4 (P<0.05), whereas concomitant pathology, lung corresponded 1 (P<0.05); lungs dynamics showed study groups: CVD, recorded often, comparison — (45% 10%, (P<0.05)).